Henry Schein says its acquisition of R. Weinstein will enhance Hawaii health care services
This spring, Henry Schein, Inc. announced that it has acquired R. Weinstein, Inc. (R. Weinstein), a provider of vaccines, medical-surgical products, and equipment to Hawaii-based health care facilities and practitioners. Headquartered in Honolulu, R. Weinstein was established in 1984 and reported sales of approximately $11 million in 2024.
Ty Ford, Vice President and General Manager of Henry Schein Medical, provided Repertoire Magazine with more insights on the acquisition.
What motivated Henry Schein to acquire R. Weinstein Inc.?
Our appreciation for the business Richard Weinstein established in Hawaii runs deep, and our teams have had a connection for years. Much like Henry Schein started serving providers in Queens, New York, the R. Weinstein team has dedicated over 40 years to providing tremendous service to the local health care market throughout the Hawaiian Islands. We are delighted to support their continued mission of serving health care professionals in Hawaii, and we look forward to doing so for many years to come.
What about R. Weinstein joining Henry Schein? What were some of the motivations and business synergies?
We recognized a strong synergy between R. Weinstein and our customer base of providers combined with our supplier community on the Islands. Because of this alignment, the decision to integrate our distribution and product category strengths with R. Weinstein’s local talent and presence offered an ideal opportunity for us to collaborate.
How will the acquisition enhance Henry Schein’s product offerings or services?
Now that we have a local presence in Hawaii, we have improved upon our best-in-industry distribution capabilities, offering reduced transit times for items that may require longer than anticipated delivery schedules.
How will R. Weinstein Inc.’s customers be affected by the acquisition?
R. Weinstein’s customers will experience a broader product range, allowing practitioners to consolidate more purchases through one distributor.
What’s unique about providing products and services to the Hawaii healthcare market? How does Henry Schein plan to leverage R. Weinstein’s expertise and capabilities in the medical distribution field in Hawaii?
To succeed, it’s crucial to prioritize respect for local Hawaiian values. By embracing the spirit of Aloha and understanding the rich cultural heritage of Hawaii, Henry Schein can build strong relationships with Hawaiian physicians and health care professionals. This approach will not only foster a positive business environment, but also contribute to the well-being of the community.
Will there be any changes to the distribution channels or product lines for existing R. Weinstein customers?
We are committed to ensuring a seamless experience for our customers, with no anticipated changes or disruptions.
How does this acquisition fit into Henry Schein’s broader strategic goals for growth?
We continue to pursue strategic acquisitions of regional distributors to expand our market presence, enhance our distribution network, and better serve health care professionals so they can continue providing high-quality patient care.
Will there be any significant changes to the operational structure following the acquisition?
No significant changes are anticipated.